Understanding the molecular mechanisms of transcriptional regulation, including the roles of specific enhancers and the formation of specific protein complexes like enhanceosomes, is crucial for developing targeted therapies. For example, drugs that inhibit the BCR-ABL1 kinase activity have been successful in treating CML.